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Abstract
Background: Generating autologous pluripotent stem cells for therapeutic applications will require the development of
efficient DNA-free reprogramming techniques. Transfecting cells with in vitro-transcribed, protein-encoding RNA is a
straightforward method of directly expressing high levels of reprogramming proteins without genetic modification.
However, long-RNA transfection triggers a potent innate immune response characterized by growth inhibition and the
production of inflammatory cytokines. As a result, repeated transfection with protein-encoding RNA causes cell death.
Methodology/Principal Findings: RNA viruses have evolved methods of disrupting innate immune signaling by destroying
or inhibiting specific proteins to enable persistent infection. Starting from a list of known viral targets, we performed a
combinatorial screen to identify siRNA cocktails that could desensitize cells to exogenous RNA. We show that combined
knockdown of interferon-b (Ifnb1), Eif2ak2, and Stat2 rescues cells from the innate immune response triggered by frequent
long-RNA transfection. Using this technique, we were able to transfect primary human fibroblasts every 24 hours with RNA
encoding the reprogramming proteins Oct4, Sox2, Klf4, and Utf1. We provide evidence that the encoded protein is active,
and we show that expression can be maintained for many days, through multiple rounds of cell division.
Conclusions/Significance: Our results demonstrate that suppressing innate immunity enables frequent transfection with
protein-encoding RNA. This technique represents a versatile tool for investigating expression dynamics and protein
interactions by enabling precise control over levels and timing of protein expression. Our finding also opens the door for
the development of reprogramming and directed-differentiation methods based on long-RNA transfection.
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Introduction
Somatic cells can be reprogrammed to a pluripotent-stem-cell
state by maintaining expression of specific combinations of
proteins through several rounds of cell division [1–7]. Although
methods of reprogramming human somatic cells using non-viral
DNA vectors have been reported [8,9], the risk of genomic
disruption may limit the therapeutic potential of these techniques.
Reprogramming by direct protein transduction has also been
demonstrated [10,11], however reprogramming human cells using
recombinant proteins is currently an inefficient process. We
postulated that expressing reprogramming proteins by repeated
transfection with protein-encoding RNA could avoid the limita-
tions of both DNA- and protein-based reprogramming techniques,
however we discovered that long RNA triggers a potent innate
immune response in human cells, even when the RNA is capped
and polyadenylated to mimic eukaryotic mRNA. To solve this
problem, we developed a method of suppressing innate immunity
to enable frequent transfection with protein-encoding RNA.
The mechanisms by which cells distinguish endogenous RNA
from the exogenous RNA produced during viral infection are the
subject of ongoing investigation and debate [12–18]. In humans,
exogenous RNA is a pathogen-associated molecular pattern
(PAMP) for which toll-like receptor 3,7/8 (Tlr3,7/8) [19–22],
and members of the Rig1 receptor family [12] are pattern-
recognition receptors (PRRs). Once activated, these PRRs initiate
cascades of intracellular signaling that result in upregulation of
PRRs, hypersensitizing cells to subsequent exposure to exogenous
RNA. PRR activation also results in the production of type I
interferons, which hypersensitize nearby cells. In addition, long
RNA binds and activates Eif2ak2, blocking translation of both
exogenous and endogenous RNA [23,24]. Although the innate
immune response to exogenous RNA is initiated and regulated by
intra- and extracellular signaling networks containing a great deal
of redundancy, RNA viruses have evolved methods of disrupting
these pathways by destroying or inhibiting specific immune-related
proteins to enable persistent infection [25]. We hypothesized that
mimicking viral immunoinhibition by co-transfecting cells with an
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immune-related proteins could desensitize cells to exogenous
RNA, and thus enable repeated long-RNA transfection.
Results
We synthesized capped, polyadenylated transcripts containing
the b-globin (Hbb)5 9- and 39-untranslated regions (UTRs) [26–29]
and the Oct4, Sox2, Klf4, c-Myc, Utf1, Nanog, Lin28, MyoD1,
and Aicda coding sequences (Fig. 1A,B), and transfected human
adult-dermal and fetal-lung fibroblasts using both electroporation
and lipid-based transfection reagents. Electroporating cells with
1 mg of each RNA (in a 50 mL total volume) resulted in protein
expression at or above ES-cell levels within 6 hours for Oct4,
Sox2, and Nanog (Fig. 1C), and immunostaining showed correct
sub-cellular localization (Fig. 1D). Transfected cells quickly
upregulated many genes involved in the immune response to viral
RNA including Ifnb1, Tlr3, Rarres3, Eif2ak2, Stat1,2, Ifit1,2,3,5,
Oas1,2,3,L, and Isg20 (Fig. 2A). Performing a second transfection
after 48 hours resulted in significant cell death (Fig. 2B).
We previously showed that combined, siRNA-mediated
knockdown of immune-related proteins could rescue primary
human fibroblasts from the cell death caused by frequent
transfection with protein-encoding in vitro-transcribed (ivT)
RNA [30]. However, effective combinations all included siRNA
targeting p53, suggesting incomplete immune suppression. To
identify more effective immunosuppressive siRNA mixtures, we
conducted a two-stage combinatorial siRNA screen starting from
a list of known viral targets (Fig. 2C). In both stages, fibroblasts
were electroporated with siRNA three times at 48-hour intervals
(Table S1). RNA encoding Lin28 was included in the second and
third transfections. Cells were counted 24 hours after the last
transfection to assess viability. In the first stage, we transfected
cells with siRNA targeting a single gene from the following list:
Ifnb1, Tlr3, Rarres3, Eif2ak2, Stat1, Stat2, Tp53,a n dCdkn1a. The
highest viability was observed in cultures transfected with siRNA
targeting either Ifnb1 or Eif2ak2. In the second stage, we co-
transfected cells with siRNA mixtures, all including siRNA
targeting both Ifnb1 and Eif2ak2. Combined knockdown of Ifnb1
and Eif2ak2 resulted in a significant increase in cell survival
compared to cells transfected with protein-encoding RNA only
(p=0.03), while adding siRNA targeting Stat2 resulted in
complete rescue of the cells (p,0.005), which continued to
proliferate at a rate comparable to the mock-transfected control.
Using this technique, we were able to transfect fibroblasts every
24 hours with RNA encoding Oct4, Sox2, Klf4, and Utf1, a
combination of factors capable of reprogramming human
fibroblasts to a pluripotent stem-cell state [31] (Fig. 2D). Many
transfected cells expressed high levels of all four factors, and
many mitotic cells were observed (Fig. 2E).
Figure 1. Long-RNA transfection yields ES-cell-level expression of reprogramming proteins in primary human fibroblasts. A. The
transcribed strand of an Hbb-UTR-stabilized in vitro-transcription template encoding an arbitrary protein. The long arrow indicates the first
transcribed base, and short arrows indicate restriction-enzyme cleavage sites. B. In vitro-transcribed RNA encoding reprogramming proteins. C.
Western blots showing expression levels and lifetimes of Oct4, Sox2, Nanog, Lin28, and MyoD1 proteins in MRC-5 human fetal lung fibroblasts
transfected with protein-encoding RNA, relative to levels in hES (H9) and rhabdomyosarcoma (Rh30) cells. b-actin was used as a loading control. Left
panels: The amount of RNA per 50 mL electroporation volume was varied as indicated. Cells were lysed 6 hours after transfection. Right panels: Cells
were transfected with 1 mg of RNA, and lysed at the indicated times. D. Expression and nuclear localization of Oct4, Sox2, Klf4, Utf1, Nanog, Lin28, and
MyoD1 protein following long-RNA transfection. Cells were fixed and stained 6–12 hours after transfection. For each protein, identical camera
settings and exposure times were used for the RNA-transfected and mock-transfected samples.
doi:10.1371/journal.pone.0011756.g001
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PLoS ONE | www.plosone.org 2 July 2010 | Volume 5 | Issue 7 | e11756Figure 2. Innate immune suppression enables frequent long-RNA transfection. Combinatorial siRNA screening identifies siRNA cocktails
that rescue cells from the innate immune response triggered by long-RNA transfection. A. Upregulation of innate immune genes following long-RNA
transfection. MRC-5 fibroblasts were transfected with 0.4 mg of RNA per well of a 24-well plate using lipids. Expression of innate immune genes was
measured by quantitative RT-PCR 24 hours after transfection. Gapdh was used as a loading control. Error bars indicate the standard deviation of
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level expression of biologically active protein through multiple
rounds of cell division, we repeatedly transfected fibroblasts with
siRNA targeting Ifnb1, Eif2ak2, Stat2,a n dTlr3, and RNA encoding
Lin28. Lin28 is a cytoplasmic, RNA-binding protein that is highly
expressed both in embryonic stem cells, where it regulates cell
growth [32], and in several cancers where it interferes with the
maturation of members of the let7 family of miRNAs [33–35],
which regulate Hmga2 and downstream targets such as Snai1 that
promotemetastasisand invasion[36–39].Wetransfectedfibroblasts
five times at 48-hour intervals with Lin28-encoding RNA, and
measured the levels of Lin28 protein and let7a miRNA (Fig. 3A).
Lin28 protein was detected as early as six hours after the first
transfection, remained highly expressed for two to three days, and
was detected up to five days after each transfection. The level of
let7a miRNA began to decrease two days after the first transfection,
and in cells transfected only once, reached approximately 50% of
the level in mock-transfected cells (p=0.02), while in repeatedly
transfected cells the level of let7a continued to decrease, reaching
approximately 10% of the level in mock-transfected cells one day
after the fifth transfection (p=0.004) (Fig. 3B). Regardless of the
number of transfections, let7a expression returned to normal levels
approximately four days after the final transfection. The level of
let7a miRNA in cells repeatedly transfected with MyoD1-encoding
RNA remained within 70% of the level in mock-transfected cells,
suggesting that the decrease in let7a expression following transfec-
tionwith Lin28-encoding RNAwasnot a non-specificeffectof long-
RNA transfection (Fig. 3C). The observed decrease in the level of
mature let7a miRNA in cells transfected five times over the course
of ten days with Lin28-encoding RNA indicates both that each
transfection was efficient, and that the translated protein was active.
We next used long-RNA transfection to express other known
reprogramming proteins. Many of these proteins are transcription
factors, which, unlike Lin28, must translocate to the nucleus and
interact with genomic DNA to exert their function. We
electroporated fibroblasts with RNA encoding the skeletal-muscle
master gene MyoD1, and detected a high level of MyoD1 protein
six hours after transfection (Fig. 3D). Two targets of MyoD1 that
are normally silenced in fibroblasts, M-cadherin (Cdh15) and
desmin (Des), were detected as early as six hours after transfection,
and their expression peaked after 12–24 hours (Fig. 3E). Interest-
ingly, expression of Cdh15 and Des in cells treated with the
demethylating agent 5-aza-dC showed similar dynamics, but
reached a peak level ten times higher than in the untreated cells,
suggesting that MyoD1-induced activation of Cdh15 and Des in
fibroblasts is inhibited by genomic methylation.
Because of the high transfection efficiency and activity of
proteins expressed by long-RNA transfection, we hypothesized
that this technique could be used to investigate early targets of
reprogramming factors in somatic cells. Genes encoding plurip-
otent-stem-cell master regulators such as Oct4 and Nanog are highly
methylated in somatic cells, and as a result transient expression of
proteins that promote transcription of these genes (Oct4, Sox2,
and Nanog, for example) does not immediately cause their
expression. Instead, somatic cell reprogramming may first require
downregulation of somatic-cell genes, together with upregulation
of ES-cell genes that are not completely silenced in somatic cells.
One such gene, Hmga2, encodes a small chromatin-associated
protein that cooperates with other factors to regulate gene
expression. Hmga2 is highly expressed in embryonic stem cells
[40], young neural stem cells [41], and many human cancers, and
is moderately expressed in various adult tissues including
fibroblasts. Overexpressing Hmga2 induces pituitary tumours in
mice by binding to and inhibiting retinoblastoma protein [42], a
tumour suppressor. Hmga2-induced pituitary adenomas exhibit
.5-fold downregulation of Sox2 compared with normal pituitary
tissue [43]. We hypothesized that a reciprocal relationship might
exist as a mechanism by which Sox2-expressing stem cells regulate
Hmga2 expression. We transfected fibroblasts with RNA encoding
Oct4, Sox2, Nanog, Lin28 or MyoD1, and measured expression of
Hmga2 after 24 hours (Fig. 3F). As expected, cells transfected with
RNA encoding Lin28 (which downregulates let7 miRNA, which
itself downregulates Hmga2) showed slight overexpression of Hmga2
(p=0.03), while the level of Hmga2 mRNA in cells transfected with
RNA encoding Nanog was approximately 3.5 times that in mock-
transfected cells (p=0.002), and expression in cells transfected
with RNA encoding Sox2 was approximately 0.5 times that in
mock-transfected cells (p=0.002). The high level of Hmga2
expression in ES cells, combined with the upregulation of Hmga2
observed in fibroblasts transfected with RNA encoding Nanog
suggests that Hmga2 may be an early downstream target of Nanog
in fibroblasts during reprogramming.
To determine whether downregulation of Hmga2 by Sox2 is
sufficient to counteract Hmga2 upregulation caused by inhibition of
let7, we co-transfected cells with a let7-miRNA inhibitor and RNA
encoding Sox2, and measured Hmga2 expression after 24 hours
(Fig. 3G). While cells transfected with only the let7 inhibitor
showed approximately 3-fold upregulation of Hmga2, those
transfected with both the inhibitor and Sox2-encoding RNA
expressed Hmga2 at the same level as mock-transfected cells,
suggesting that an ES-cell level of Sox2 is sufficient to replace let7-
mediated downregulation of Hmga2. The competing roles of Sox2,
Nanog, and Lin28 in the regulation of Hmga2 highlight the
complex interactions between these factors that likely take place
during reprogramming.
Discussion
Long-RNA transfection is a versatile tool for investigating
expression dynamics and protein interactions. In addition, the
ability to maintain high-level expression of defined proteins in
replicate samples. B. Repeated long-RNA transfection causes cell death in human fibroblasts. MRC-5 fibroblasts were electroporated twice with
0.5 mg/50 mL of Lin28-encoding RNA at 48-hour intervals. Samples of cells transfected with RNA (black circles) and mock-transfected cells (gray
squares) were trypsinized and counted at the indicated times. Data points and error bars indicate the mean and standard error of two independent
experiments. Data points are connected for clarity. C. Combined knockdown of Ifnb1, Eif2ak2, and Stat2 rescues cells from the innate immune
response triggered by frequent long-RNA transfection. MRC-5 fibroblasts were transfected as in (B), but with the indicated siRNA on day 0, and 0.5 mg
of Lin28-encoding RNA and additional siRNA on days 2 and 4 (Table S1). Samples of cells were trypsinized and counted 24 hours after the second
long-RNA transfection (day 5). Values indicate cell count relative to mock-transfected cells.
{Standard error of replicate samples (n=4). *p,0.05,
**p,0.005. D. Frequent transfection of primary human fibroblasts with a mixture of RNA encoding the reprogramming proteins Oct4, Sox2, Klf4, and
Utf1 yields sustained, ES-cell-level expression. Cells were reverse transfected with an immunosuppressive siRNA cocktail (Lipofectamine RNAiMAX,
Invitrogen), and then transfected with protein-encoding RNA (0.1 mg of RNA per factor per well) using lipids every day for three days. Cells were fixed
and stained 8 hours after the last transfection. For each protein, identical camera settings and exposure times were used for the mock-transfected,
RNA-transfected, and hES-cell samples. E. Cells expressing reprogramming proteins undergo mitosis. Cells were transfected as in (D). Utf1 localized to
chromosomes in mitotic cells (arrow).
doi:10.1371/journal.pone.0011756.g002
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the potential importance of long-RNA transfection in the
development of reprogramming methods for therapeutic applica-
tions.Although techniquesforinvitrosynthesisoflargequantitiesof
capped, polyadenylated RNA have been available for some time
[44,45], as have a variety of delivery techniques including
electroporation and lipid-mediated transfection [26,46], the potent
immune response triggered by long-RNA transfection has largely
limited its use to studies of immunity, and has prevented the
development of RNA-based reprogramming methods.
Here we have shown that combined knockdown of Ifnb1,
Eif2ak2, and Stat2 rescues human fibroblasts from the innate
Figure 3. Repeated long-RNA transfection yields sustained, high-level expression of active proteins that modulate downstream
targets. A. Sustaining high levels of Lin28 protein expression by frequent transfection with Lin28-encoding RNA. MRC-5 fibroblasts pre-transfected
with a cocktail of siRNAs targeting Ifnb1, Eif2ak2, Stat2, and Tlr3 were transfected five times with 0.5 mg of Lin28-encoding RNA and additional siRNA
at 48-hour intervals. Cells were lysed at the indicated times, and the amount of Lin28 protein was analyzed by western blot. b-actin was used as a
loading control. B. Sustained expression of Lin28 downregulates its target, mature let7 miRNA. Transfections were conducted as in (A). Data points
indicate mature let7a levels in cells transfected once (circles), twice (squares), three times (diamonds), four times (triangles), or five times (crosses),
relative to the level in mock-transfected cells. A solid smoothed line connects data points corresponding to cells transfected once, and a dashed
smoothed line connects data points corresponding to cells transfected five times (dark symbols). U47 RNA was used as a loading control. Error bars
indicate the standard error of replicate samples. C. let7a downregulation is Lin28-specific. Cells were transfected as in (A), but with MyoD1-encoding
RNA. Error bars indicate the standard error of replicate samples. D. Expression of MyoD1 protein in fibroblasts. Fibroblasts cultured for three days with
or without 2.5 mM 5-aza-dC (AZA) were electroporated with 1 mg/50 mL of MyoD1-encoding RNA. Cells were lysed at the indicated times, and the
amount of MyoD1 protein in each sample was analyzed by western blot. E. Expression of MyoD1 in fibroblasts activates its normally silent targets,
Cdh15 and Des in a methylation-dependent manner. Cells were transfected as in (D), and expression of Cdh15 and Des was measured by RT-PCR at the
indicated times (squares, mock-transfected cells; circles, RNA-transfected cells). F. Regulation of Hmga2 expression by reprogramming proteins.
Hmga2 expression in fibroblasts transfected with RNA encoding the indicated protein was measured by RT-PCR 24 hours after transfection. Values are
given relative to mock-transfected cells. Gapdh was used as a loading control. *p,0.005. G. Hmga2 expression in fibroblasts co-transfected with RNA
encoding reprogramming proteins and a let7a inhibitor was measured by RT-PCR, 24 hours after transfection. Values are given relative to mock-
transfected cells that received neither long RNA nor the let7a inhibitor. Gapdh was used as a loading control. *p=0.004.
doi:10.1371/journal.pone.0011756.g003
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encoding RNA, and enables sustained, high-level expression of
active proteins. Interestingly, while we previously found that p53
knockdown alone increased the rate of recovery of cells transfected
with long RNA [30], we now demonstrate that combined
knockdown of Ifnb1, Eif2ak2, and Stat2 is sufficient to allow
frequent transfection with protein-encoding RNA, eliminating the
need for p53 knockdown, which may facilitate the use of long-
RNA transfection in therapeutic applications as p53 is crucial for
the maintenance of genomic integrity.
Long-RNA transfection enables precise control over the timing
and level of expression of encoded proteins. We used this
characteristic to investigate the regulation of downstream targets
of the cytoplasmic RNA-binding protein Lin28, and the
transcription factor and skeletal-muscle master regulator MyoD1.
In addition, we used long-RNA transfection to search for early
targets of reprogramming factors in fibroblasts, and we provide
evidence that the pluripotent-stem-cell master genes and repro-
gramming factors Sox2 and Nanog are novel upstream effectors of
the proto-oncogene Hmga2.
Finally, while we have shown that siRNA-mediated immuno-
suppression alone is sufficient to enable frequent long-RNA
transfection, the use of small-molecule immunosuppressants (for
example, glucocorticoids such as cortisone [47] or dexametha-
sone), and/or protein immunosuppressants such as B18R, a
vaccinia-virus-encoded soluble type I interferon receptor [48,49],
either alone or in combination with siRNA may increase the
quantity of RNA that can be delivered to cells and the frequency
of transfection, two parameters that will likely be critical in the
design of efficient RNA-based reprogramming methods. The
discovery that innate immune suppression enables frequent long-
RNA transfection thus provides a clear path toward the
development of culture and transfection protocols for RNA-based
reprogramming.
Materials and Methods
Cell Culture
MEF cultures were prepared from E13 CF-1 mice (Charles
River Laboratories) according to an approved protocol (MIT
Committee on Animal Care #0307-023-10). Samples tested
negative for mycoplasmal contamination by both DNA fluoro-
chrome staining and live-culture methods. H9 human embryonic
stem cells were obtained from the National Stem Cell Bank at
passage 24, and were cultured on irradiated MEFs as described
[50,51]. Cells from frozen stocks (in hES-Cell Media +10%
DMSO +30% Defined FBS) were seeded on plates coated with
basement-membrane extract (Pathclear, Trevigen), and cultured
in media conditioned for 24 hours on irradiated MEFs. Primary
human fibroblasts from normal fetal lung tissue (MRC-5) or from
normal adult skin (CCD-1109Sk) were obtained from the ATCC
and were cultured according to their recommendations.
In Vitro-Transcription
dsDNA templates were prepared as described [30]. Briefly, total
RNA was extracted from H9 hES cells and enriched for poly(A)+
mRNA (Oligotex, Qiagen). Oct4, Sox2, Klf4, c-Myc, Utf1,
Nanog, Lin28, MyoD1, and Aicda coding sequences, and b-
globin UTRs were reverse transcribed using an RNase H- reverse
transcriptase (MonsterScript, Epicentre). Template components
were amplified with a high-fidelity polymerase (Phusion Hot Start,
NEB or KAPA HiFi, Kapa Biosystems) and ligated with E.coli
DNA ligase (NEB). Capped, poly(A)+ RNA was synthesized using
the mScript mRNA Production System (Epicentre). The temper-
ature and duration of the in vitro-transcription reaction were
optimized for specificity and yield as described [30]. Transcripts
were analyzed both before and after poly(A) tailing by denaturing
formaldehyde-agarose gel electrophoresis. Primers used for
assembly of in vitro-transcription templates are given in Table S2.
Long-RNA Transfection
Lipid-mediated transfections (TransIT-mRNA, Mirus) were
performed according to the manufacturer’s instructions. Electro-
poration was performed as described [30]. Briefly, cells were
trypsinized, washed once in Opti-MEM (Invitrogen), and
resuspended in a total volume of 50 mL of Opti-MEM in a
standard electroporation cuvette with a 2 mm gap. A 150uF
capacitor charged to 150V was discharged into the cuvette to
electroporate the cells. Warm media was added, and the cells were
plated and cultured using standard protocols.
Quantitative RT-PCR
TaqMan Gene Expression Assays (Applied Biosystems) were
used in one-step RT-PCR reactions (iScript One-Step RT-PCR
Kit, Bio-Rad) consisting of a 50C, 10 min reverse transcription
step, followed by an initial denaturation step of 95C for 5 min, and
45 cycles of 95C for 15 sec and 55C for 30 sec.
siRNA-Mediated Knockdown
Cells were electroporated in Opti-MEM containing the
indicated siRNAs (Silencer Select or Anti-miR, Applied Biosys-
tems), each at a final concentration of 100–800 nM (Table S1).
Immunocytochemistry
Cells were rinsed in TBST and fixed for 10 minutes in 4%
paraformaldehyde. Cells were then permeabilized for 10 minutes
in 0.1% Triton X-100, blocked for 30 minutes in 1% casein, and
incubated with appropriate antibodies (Table S3).
Western Blot
Whole-cell lysates (Qproteome Mammalian Protein Prep Kit,
Qiagen) were separated on a 12% polyacrylamide gel (ProSieve
50, Lonza) under reducing, denaturing conditions. Proteins were
transferred onto a PVDF membrane (Immobilon-P, Millipore) in
CAPS buffer, pH 11. Membranes were blocked in 5% skim milk,
and probed with appropriate antibodies (Table S3). b-actin was
used as a loading control.
Supporting Information
Table S1 Concentrations of siRNA used in the combinatorial
screen.
Found at: doi:10.1371/journal.pone.0011756.s001 (0.03 MB
DOC)
Table S2 Primers for in vitro-transcription template assembly.
Found at: doi:10.1371/journal.pone.0011756.s002 (0.03 MB
DOC)
Table S3 Antibodies.
Found at: doi:10.1371/journal.pone.0011756.s003 (0.03 MB
DOC)
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